Return to Listing

1 result(s) for

PI Name Protocol # Title
Alexey Danilov STUDY00015747 A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with TGR-1202 (Umbralisib) Compared to Obinutuzumab in Combination with Chlorambucil in Patients with Chronic Lymphocytic Leukemia (CLL)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080